Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

New psychopharmacology research finds women are more sensitive to some of the effects of methamphetamine

by Eric W. Dolan
October 5, 2019
in Psychopharmacology
(Photo credit: Johanna Goodyear)

(Photo credit: Johanna Goodyear)

Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

Woman tend to be more sensitive to the psychomotor-related behavioral and subjective effects of methamphetamine than men, according to a new study published in the journal Psychopharmacology. The findings could help explain why women tend to transition from recreational methamphetamine use to dependence more quickly.

“We were interested in exploring individual differences in acute or early drug responses, prior to the development of a drug use disorder,” explained study author Leah Mayo, a postdoctoral research fellow at Linköping University in Sweden.

“While many people will try drugs throughout their life, only a minority (albeit, a significant minority) will develop a substance use disorder. Doing studies like these in healthy, non-dependent humans allows us to understand how people vary in response to a drug and how that variation may make them more vulnerable, or resilient, to the development of a drug use disorder.”

“In particular, clinical and epidemiological reports suggest that women are more vulnerable to developing a methamphetamine use disorder. However, it is unclear what contributes to these different drug use trajectories. Here, we asked whether gender differences in response to methamphetamine exist early on, prior to the development of problematic use.”

In the study, 44 men and 29 women completed four sessions in which they received either placebo or methamphetamine (20 mg) under double-blind conditions.

About 30 minutes into each session, the participants completed a monetary incentive delay in which they had to respond quickly to a target in order to win or avoid losing money. The participants also completed assessments of mood and drug effects, and the researchers monitored their blood pressure and heart rate.

“We find that women are more sensitive to psychomotor-related effects of methamphetamine than men. In particular, women report feeling more ‘vigor’ and less ‘fatigue’ after taking the drug. Behaviorally, they also show faster reaction times in a reward-processing task,” Mayo told PsyPost.

“Together, we propose that this heightened sensitivity to the behavioral and subjective effects of methamphetamine in women may render them more likely to use the drug again, and perhaps escalate use over time. This supports clinical data showing that female methamphetamine users transition more quickly from recreational use to dependence than their male counterparts.”

The findings provide some new insights into the effects of methamphetamine, but more research is needed to clarify the relationship between these effects and addiction.

“We have shown that women are more sensitive to some of the effects of methamphetamine and we hypothesize that this sensitivity may render them more vulnerable to develop problematic use patterns. However, we still don’t know if this is true; that is, are those most sensitive to these drug effects actually the ones who are more vulnerable to developing a use disorder?” Mayo explained.

“We also don’t know how these effects change over time. More specifically, how do the behavioral and subjective responses to methamphetamine change as drug use escalates? There are still many clinical questions to be answered, but we hope that this study provides a starting point for understanding gender-based differences in methamphetamine effects and consumption.”

“One interesting observation is that the differences we report between men and women seem to be specific to methamphetamine. Work from others suggest that similar gender differences are not evident in response the closely related drug, D-amphetamine,” Mayo added.

“Strikingly, very similar effects have been reported in preclinical animal models: psychomotor effects of methamphetamine, but not D-amphetamine, differ between male and female rodents. The fact that this sex-based difference also exists in preclinical animal models opens up the avenue for gaining a more mechanistic understanding of the neurobiological underpinnings of these behaviors.”

The study, “Gender differences in the behavioral and subjective effects of methamphetamine in healthy humans“, was authored by Leah M. Mayo, Elisabeth Paul, Jessica DeArcangelis, Kathryne Van Hedger, and Harriet de Wit.

TweetSendScanShareSendPin2ShareShareShareShareShare

RELATED

High caffeine intake linked to greater psychological distress in people with depression
Caffeine

High caffeine intake linked to greater psychological distress in people with depression

May 28, 2025

A new study finds that individuals with a history of depression who consume high amounts of caffeine tend to report greater psychological distress. Genetic differences also appear to influence how much caffeine people drink and how sensitive they are.

Read moreDetails
Clinical psychologists appear to have cautiously favorable attitudes toward psychedelic-assisted mental health treatments
Psilocybin

Only a specific dose of psilocybin induces lasting antidepressant-like effects, study suggests

May 27, 2025

A recent study found that a single moderate dose of psilocybin produced lasting antidepressant-like effects in rats, while higher doses led to unwanted side effects. The findings highlight the importance of optimal dosing.

Read moreDetails
New research shows decaf coffee can mimic caffeine’s effects in habitual drinkers
Caffeine

New research shows decaf coffee can mimic caffeine’s effects in habitual drinkers

May 27, 2025

Drinking coffee might wake you up even without the caffeine. Researchers found that habitual coffee drinkers responded similarly to both regular and decaf coffee, pointing to the influence of expectation and ritual on alertness and brain activity.

Read moreDetails
Cannabidiol shows promise for treating Alzheimer’s in mice by targeting brain hyperactivity
Alzheimer's Disease

Cannabidiol shows promise for treating Alzheimer’s in mice by targeting brain hyperactivity

May 26, 2025

In a study using an Alzheimer’s disease mouse model, researchers found that cannabidiol reduced memory loss and brain abnormalities. The compound worked by enhancing the function of glycine receptors, which help regulate neuronal activity in the brain's memory center.

Read moreDetails
Psilocybin and escitalopram produce antidepressant effects via distinct brain mechanisms, study suggests
Depression

Psilocybin and escitalopram produce antidepressant effects via distinct brain mechanisms, study suggests

May 25, 2025

A new study using brain scans found that psilocybin and escitalopram reduce depression symptoms through different neural mechanisms. While escitalopram dampened emotional brain activity, psilocybin preserved or slightly increased it, suggesting distinct pathways to recovery.

Read moreDetails
ADHD drug shows promise in treating some symptoms of Alzheimer’s disease
Depression

Withdrawal symptoms are common after stopping antidepressants

May 23, 2025

Researchers analyzed data from 35 studies and found that over 40% of antidepressant users experienced withdrawal symptoms, including dizziness, irritability, and mood disturbances. The findings suggest the need for better tapering strategies and patient education.

Read moreDetails
Pills spilling out of a bottle on a table
ADHD

Common blood pressure drug shows promise for treating ADHD symptoms

May 22, 2025

Amlodipine, typically used for hypertension, may have brain-based effects that make it a candidate for ADHD treatment, according to new research.

Read moreDetails
Psychedelic’s anti-anxiety effects can be separated from hallucinations by targeting specific brain circuits
Neuroimaging

Psychedelic’s anti-anxiety effects can be separated from hallucinations by targeting specific brain circuits

May 19, 2025

A mouse study published in Science shows that stimulating a specific set of brain cells activated by a psychedelic drug can reduce anxiety without triggering hallucination-like behavior, pointing to new possibilities for targeted mental health treatments.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Consciousness remains a mystery after major theory showdown

Sheriff partisanship doesn’t appear to shape extremist violence in the United States

East Asians more open to chatbot companionship than Westerners

Frequent fights may explain why neurotic people feel less satisfied in relationships

Coronavirus anxiety linked to obsessive healthy eating behaviors during the pandemic

A common calorie-free sweetener alters brain activity and appetite control, new research suggests

New research highlights spite as a motivator of conspiracy theory beliefs

Five reasons young-onset dementia often goes unrecognized

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy